NDC 49702-202 – Combivir

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC49702-202

Product details

Brand name
Combivir
Generic name
lamivudine and zidovudine
Labeler
ViiV Healthcare Company
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA020857
Marketed since
October 19, 2010
Marketing end
February 28, 2027
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Combivir →

Package NDC codes (1)

Package NDCDescriptionSince
49702-202-1860 TABLET, FILM COATED in 1 BOTTLE (49702-202-18)Oct 19, 2010